{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:13:59Z","timestamp":1794410039745,"version":"4.9.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ymgme.2023.107689","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T15:58:45Z","timestamp":1692979125000},"page":"107689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Heptanoic and medium branched-chain fatty acids as anaplerotic treatment for medium chain acyl-CoA dehydrogenase deficiency"],"prefix":"10.1016","volume":"140","author":[{"given":"Anuradha","family":"Karunanidhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakuntala","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"D'Annibale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton","family":"Van't Land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Vockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Walid","family":"Mohsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2023.107689_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/epi4.12308","article-title":"Randomized trial of add-on triheptanoin vs medium chain triglycerides in adults with refractory epilepsy","volume":"4","author":"Borges","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.ymgme.2023.107689_bb0010","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ejpn.2018.07.014","article-title":"A pilot study of add-on oral triheptanoin treatment for children with medically refractory epilepsy","volume":"22","author":"Calvert","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2023.107689_bb0015","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10545-017-0085-8","article-title":"Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial","volume":"40","author":"Gillingham","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107689_bb0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13023-017-0713-2","article-title":"A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood","volume":"12","author":"Hainque","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2023.107689_bb0025","series-title":"JIMD Reports","first-page":"19","article-title":"Triheptanoin: A rescue therapy for cardiogenic shock in carnitine-acylcarnitine translocase deficiency","volume":"39","author":"Mahapatra","year":"2018"},{"key":"10.1016\/j.ymgme.2023.107689_bb0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fncel.2018.00274","article-title":"Impairments in oxidative glucose metabolism in epilepsy and metabolic treatments thereof","volume":"12","author":"McDonald","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ymgme.2023.107689_bb0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/jnnp-2015-311475","article-title":"Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency","volume":"87","author":"Mochel","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2023.107689_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11940-017-0473-2","article-title":"Treatment opportunities in patients with metabolic myopathies","volume":"19","author":"\u00d8rngreen","year":"2017","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.ymgme.2023.107689_bb0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ymgme.2015.10.005","article-title":"Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: review of 15 years experience","volume":"116","author":"Roe","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107689_bb0050","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10545-017-0103-x","article-title":"A double-blind, placebo-controlled trial of triheptanoin in adult polyglucosan body disease and open-label, long-term outcome","volume":"41","author":"Schiffmann","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107689_bb0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2015.05.014","article-title":"Reduced severity of ischemic stroke and improvement of mitochondrial function after dietary treatment with the anaplerotic substance triheptanoin","volume":"300","author":"Schwarzkopf","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymgme.2023.107689_bb0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jimd.12078","article-title":"Concerning \u201cTriheptanoin vs trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial\u201d by Gillingham et al","volume":"42","author":"Shoffner","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107689_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neulet.2018.07.045","article-title":"Heptanoate is neuroprotective in vitro but triheptanoin post-treatment did not protect against middle cerebral artery occlusion in rats","volume":"683","author":"Tan","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2023.107689_bb0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/jnc.14275","article-title":"Triheptanoin protects against status epilepticus-induced hippocampal mitochondrial dysfunctions, oxidative stress and neuronal degeneration","volume":"144","author":"Tan","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2023.107689_bb0075","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ymgme.2017.02.005","article-title":"UX007 for the treatment of long chain-fatty acid oxidation disorders: safety and efficacy in children and adults following 24weeks of treatment","volume":"120","author":"Vockley","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107689_bb0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ymgme.2016.08.008","article-title":"Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders","volume":"119","author":"Vockley","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107689_bb0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s10038-018-0527-7","article-title":"Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency","volume":"64","author":"Yamada","year":"2019","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2023.107689_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jimd.12038","article-title":"Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)","volume":"42","author":"Vockley","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107689_bb0095","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/jnnp-2018-320283","article-title":"Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effect","volume":"90","author":"Hainque","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2023.107689_bb0100","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0271678X19837380","article-title":"Triheptanoin alters [U-(13)C6]-glucose incorporation into glycolytic intermediates and increases TCA cycling by normalizing the activities of pyruvate dehydrogenase and oxoglutarate dehydrogenase in a chronic epilepsy mouse model","volume":"40","author":"McDonald","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ymgme.2023.107689_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.598760","article-title":"Physiological perspectives on the use of triheptanoin as anaplerotic therapy for long chain fatty acid oxidation disorders","volume":"11","author":"Sklirou","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2023.107689_bb0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1172\/JCI0215311","article-title":"Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride","volume":"110","author":"Roe","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2023.107689_bb0115","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s40265-020-01426-5","article-title":"Correction to: Triheptanoin: first approval","volume":"80","author":"Shirley","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.ymgme.2023.107689_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymgme.2015.06.006","article-title":"Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--a retrospective chart review","volume":"116","author":"Vockley","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107689_bb0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/jimd.12480","article-title":"Mohsen, medium branched chain fatty acids improve the profile of tricarboxylic acid cycle intermediates in mitochondrial fatty acid \u03b2-oxidation deficient cells: a comparative study","volume":"45","author":"Karunanidhi","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107689_bb0130","doi-asserted-by":"crossref","first-page":"E860","DOI":"10.1152\/ajpendo.00366.2005","article-title":"Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats","volume":"291","author":"Kinman","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2023.107689_bb0135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00711807","article-title":"Prenatal diagnosis of a defect in medium-chain fatty acid oxidation","volume":"17","author":"Pollitt","year":"1994","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107689_bb0140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.gim.0000204472.25153.8d","article-title":"The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update","volume":"8","author":"Grosse","year":"2006","journal-title":"Genetics Med."},{"key":"10.1016\/j.ymgme.2023.107689_bb0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0009-8981(83)90246-2","article-title":"General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases","volume":"132","author":"Gregersen","year":"1983","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2023.107689_bb0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1126\/science.6857268","article-title":"Dicarboxylic aciduria: deficient [1-14C]octanoate oxidation and medium-chain acyl-CoA dehydrogenase in fibroblasts","volume":"221","author":"Rhead","year":"1983","journal-title":"Science"},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2023.107689_bb0155","first-page":"105","article-title":"Medium chain acyl-CoA dehydrogenase deficiency: apparent Km and Vmax values for fibroblast acyl-CoA dehydrogenase towards octanoyl CoA in patient and control cell lines","volume":"7","author":"Gregersen","year":"1984","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107689_bb0160","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/bmj.322.7293.1062","article-title":"Screening for medium chain acyl-CoA dehydrogenase deficiency is being evaluated","volume":"322","author":"Grosse","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ymgme.2023.107689_bb0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/adc.79.2.116","article-title":"Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK","volume":"79","author":"Pollitt","year":"1998","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2023.107689_bb0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00000433-199212000-00013","article-title":"Fatty liver, encephalopathy, and sudden unexpected death in early childhood due to medium-chain acyl-coenzyme A dehydrogenase deficiency","volume":"13","author":"Perper","year":"1992","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.ymgme.2023.107689_bb0175","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00431-022-04421-y","article-title":"Sudden neonatal death in individuals with medium-chain acyl-coenzyme A dehydrogenase deficiency: limit of newborn screening","volume":"181","author":"Mutze","year":"2022","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107689_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ymgme.2010.05.007","article-title":"Sudden death in medium chain acyl-coenzyme A dehydrogenase deficiency (MCADD) despite newborn screening","volume":"101","author":"Yusupov","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107689_bb0185","series-title":"Method of Use of Five and Fifteen Carbon Fatty Acids","author":"Roe","year":"2004"},{"key":"10.1016\/j.ymgme.2023.107689_bb0190","unstructured":"C. R. Roe, Method of use of five and fifteen carbon fatty acids. U.S. Patent and Trade Office, Patent number US 8,399,515 B2 (2013)."},{"key":"10.1016\/j.ymgme.2023.107689_bb0195","first-page":"424","article-title":"Metabolic reprogramming: strategy for ischemic stroke treatment by ischemic preconditioning","volume":"10","author":"Liang","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.ymgme.2023.107689_bb0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic reprogramming: the emerging concept and associated therapeutic strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ymgme.2023.107689_bb0205","doi-asserted-by":"crossref","first-page":"C125","DOI":"10.1152\/ajpcell.00247.2006","article-title":"Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells","volume":"292","author":"Wu","year":"2007","journal-title":"Am. J. Physiol. - Cell Physiol."},{"key":"10.1016\/j.ymgme.2023.107689_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2019.06.003","article-title":"An acyl-CoA dehydrogenase microplate activity assay using recombinant porcine electron transfer flavoprotein","volume":"581","author":"Zhang","year":"2019","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2023.107689_bb0215","doi-asserted-by":"crossref","first-page":"15356","DOI":"10.1021\/bi961113r","article-title":"Functional role of the active site glutamate-368 in rat short chain acyl-CoA dehydrogenase","volume":"35","author":"Battaile","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymgme.2023.107689_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085436","article-title":"Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort","volume":"9","author":"Rose","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2023.107689_bb0225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/CS20140101","article-title":"The bioenergetic health index: A new concept in mitochondrial translational research","volume":"127","author":"Chacko","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ymgme.2023.107689_bb0230","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1515\/hsz-2012-0198","article-title":"Integration of cellular bioenergetics with mitochondrial quality control and autophagy","volume":"393","author":"Hill","year":"2012","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ymgme.2023.107689_bb0235","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41598-018-19543-3","article-title":"Evaluation of mitochondrial bioenergetics, dynamics, endoplasmic reticulum-mitochondria crosstalk, and reactive oxygen species in fibroblasts from patients with complex I deficiency","volume":"8","author":"Leipnitz","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2023.107689_bb0240","doi-asserted-by":"crossref","first-page":"12651","DOI":"10.1038\/s41598-019-49014-2","article-title":"ETHE1 and MOCS1 deficiencies: disruption of mitochondrial bioenergetics, dynamics, redox homeostasis and endoplasmic reticulum-mitochondria crosstalk in patient fibroblasts","volume":"9","author":"Grings","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2023.107689_bb0245","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/hmg\/ddy403","article-title":"Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers","volume":"28","author":"Seminotti","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2023.107689_bb0250","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2020.01.005","article-title":"Clinical, biochemical, mitochondrial, and metabolomic aspects of methylmalonate semialdehyde dehydrogenase deficiency: report of a fifth case","volume":"129","author":"Dobrowolski","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107689_bb0255","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0003-2697(86)90010-2","article-title":"Amino acid analysis by HPLC: optimized conditions for chromatography of phenylthiocarbamyl derivatives","volume":"154","author":"Ebert","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2023.107689_bb0260","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1021\/ac0607616","article-title":"Simultaneous quantitative analysis of metabolites using ion-pair liquid chromatography-electrospray ionization mass spectrometry","volume":"78","author":"Coulier","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ymgme.2023.107689_bb0265","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.biochi.2014.11.007","article-title":"Kinetic and spectral properties of isovaleryl-CoA dehydrogenase and interaction with ligands","volume":"108","author":"Mohsen","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.ymgme.2023.107689_bb0270","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0076-6879(00)24236-5","article-title":"Mammalian branched-chain acyl-CoA dehydrogenases: molecular cloning and characterization of recombinant enzymes","volume":"324","author":"Vockley","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymgme.2023.107689_bb0275","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0006-2944(85)90124-3","article-title":"Fluorometric assay of acyl-CoA dehydrogenases in normal and mutant human fibroblasts","volume":"33","author":"Frerman","year":"1985","journal-title":"Biochem. Med."},{"key":"10.1016\/j.ymgme.2023.107689_bb0280","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1021\/bi026030r","article-title":"Purification and characterization of two polymorphic variants of short chain acyl-CoA dehydrogenase reveal reduction of catalytic activity and stability of the Gly185Ser enzyme","volume":"41","author":"Nguyen","year":"2002","journal-title":"Biochemistry"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223003190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223003190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T17:14:26Z","timestamp":1735233266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223003190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1096719223003190"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107689","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heptanoic and medium branched-chain fatty acids as anaplerotic treatment for medium chain acyl-CoA dehydrogenase deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107689"}}